Evidence map›Paper›PMID 39946424›Full record

ArticlePloS one2025

The importance of genetic counselling and testing in inherited eye diseases: A population-based retrospective study.

Michal Kaminer Abargel, Michal Macarov, Karen Hendler, Claudia Yahalom

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michal Kaminer AbargelFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Michal MacarovDepartment of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.
Karen HendlerDepartment of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.
Claudia YahalomFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.ORCID https://orcid.org/0000-0001-7747-3568

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeInherited eye diseases (IEDs) are among the main causes of visual impairment and blindness in children and young people worldwide. The objective of our study was to characterize the prevalence and distribution of the most common IEDs and causative genes in our population. STUDY

designRetrospective study based on medical records of patients with IEDs who underwent genetic counselling through our multidisciplinary low vision center from 2018 to 2020.

methodsData retrieved from medical files included: year of consultation, age, gender, ethnicity, diagnosis, gene variants and mode of inheritance.

results228 patients were included in our study. The most common diagnoses were inherited retinal diseases (IRDs) (41.2%) and albinism (32%). In 2018 and 2019 the number of patients reaching out for genetic counselling was between 50 and 60; this number doubled by 2020. The rate of pathogenic variant detection was 65.3%. The most common genes identified were TYR (29.2%), OCA2 (7.9%), ABCA4 (5.3%), TRPM1 (5.3%) and USH2A (4.4%).

conclusionGenetic counselling and testing became an essential part of caregiving for patients and families affected by these severe IEDs. The most common IEDs were IRDs in the Muslim population and albinism in the Jewish population. Pathogenic variants in the TYR gene were the most common in our cohort, OCA2 gene was the second in frequency, followed by ABCA4, TRPM1 and USH2A genes. We detected an increasing trend over the studied time in the number of patients reaching out for genetic counselling.

Indexed as

Eye Diseases, HereditaryGenetic CounselingGenetic TestingAdolescentAdultChildChild, PreschoolFemaleHumansInfantMaleMiddle AgedRetrospective StudiesYoung Adult

Identifiers

PMID39946424
PMCPMC11825002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.